Tempus Lens
Agentic platform for oncology drug development that helps teams design better clinical trials, target patient subgroups faster and generate evidence from Tempus's multimodal data.
Find alternatives to Tempus Lens
What it does
- Agent orchestration
- Drug discovery
- Data analysis
Features 6
- Tempus OneExecutes scientific research tasks using native access to data and models
- AI WorkspacesProvides configured environments with GPU computing for training and running models
- Target validationConnects research hypotheses with multimodal evidence and relevant patient subpopulations
- Biomarker discoveryExplores biological signals across indications using transcriptomic data and patient outcomes
- Trial designConverts natural language protocols into validated cohorts with eligibility checks
- Evidence generationProduces scientific evidence packages with audit trails documenting the underlying analysis
Sources
- Pricing
-
Official documentation · 25 Aug 2026
The 'Ways to partner' section lists licensing and embedded-team engagements; no list price is published, and tempus.com answers 429 to automated requests so the page was read in a browser.
- Description
-
Tempus' launch release (May 2026): Lens helps teams "design better clinical trials, target patient subgroups faster, and generate critical evidence in a fraction of the time"; it does not say Lens simulates trials or generates regulatory evidence.
- Sold within
-
Tempus calls Lens "the agentic platform for oncology drug development"; the page offers "CONTACT US", a "LOG IN" link and a feasibility request, noting "All feasibility requests are subject to Tempus’ internal review and approval." No plan, price or self-serve sign-up is stated.
- Intended for
-
provides scientists/researchers at biopharma companies access to de-identified real-world data; used by 19 of the top 20 largest biopharma companies
Also from Tempus AI
-
Tempus precision medicine platform Application
Clinical and genomic data platform that sequences patient samples and returns results to oncologists.
-
Tempus ECG-AF Application
AI algorithm that identifies ECG signs associated with future atrial fibrillation risk.
-
Tempus ECG-Low EF Application
AI algorithm that identifies ECG signs associated with low ejection fraction (heart-failure risk).
-
Tempus One AI agent
Generative-AI assistant for oncology providers, available in Tempus Hub and inside the EHR, that answers questions on a patient's order status, biomarker report, history and eligible clinical trials, and in the EHR transcribes visits and drafts notes and prior authorizations.
-
Tempus Next Intelligence Platform
AI-powered platform for oncology life-sciences companies that surfaces care gaps and guideline adherence from near-real-time, de-identified multimodal patient-journey data, deployed in health systems.
Open Tempus AI in the directory
Something wrong here? Send a correction — quote this product id: tempus-lens.